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Real-time determination of Kt/V can be provided by
monitoring ultraviolet absorbance of solutes in spent
dialysate. This not only overcomes dependency on error-
prone pre- and post-dialysis blood sampling; it circumvents
inaccuracies associated with estimating the urea distribution
volume and its high measurement frequency tightly reflects
the course of the dialysis. Our study compared the
ultraviolet-based spKt/V and eKt/V with the commonly used
blood-based counterparts. A first study of 16 patients
compared ultraviolet Kt/Vs against blood Kt/Vs obtained by
using the ‘gold standard’ of serial blood samples. A second
study included 18 patients and compared the ultraviolet and
blood values under routine conditions. Both studies showed
mean blood-based spKt/V and eKt/V values statistically
indistinguishable from their ultraviolet-based counterparts.
Hence, on-line monitoring of ultraviolet absorption of spent
dialysate is applicable in routine hemodialysis allowing
continuous measure of removed solutes from spent dialysate
without disturbing the patient or treatment session.
Kidney International (2010) 78, 920–925; doi:10.1038/ki.2010.216;
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Patient outcome in terms of mortality and morbidity is
strongly correlated with hemodialysis adequacy.1,2 A mini-
mum dose of 1.2 spKt/V is recommended for patients
undergoing chronic hemodialysis therapy three times a
week.3 Although recent works4 raise doubts regarding the
validity of the Kt/V to express or prescribe dialysis dosage, it
is still one of the most widely used adequacy parameters
in clinical practice.
The standard procedure for calculating Kt/V requires
blood samples before and after treatment. The major
drawbacks of the method are (i) the sampling time of the
post-dialysis blood sample, together with laboratory errors,
impairs the accuracy of the method; (ii) it is not possible to
know whether the treatment is adequate or not before it
finishes, it is therefore not possible to take corrective
measures during treatment; and (iii) the obtained Kt/V value
is a single-pool Kt/V, which does not account for the urea
rebound effect. Ideally, an equilibrated blood sample taken
30min after the end of therapy would deliver the actual or
equilibrated Kt/V. However, the impracticability of such an
approach requires estimation of the equilibrated sample by
using (in most cases) the rate-adjustment method, which
leads to further inaccuracies.5,6
During recent years, different methods and devices to
measure the Kt/V on-line have been developed. All deliver
Kt/V measurements before the treatment’s end, overcoming
the drawback of the blood-sampling method. These
measurement systems can be classified in three groups
according to the technical principle: conductivity-based
methods, urea sensors, and spectrophotometric methods.
Urea sensors7,8 are measuring cells that continually
monitor urea concentration in effluent dialysate. The
exponential factor of the time decay of concentration
matches the Kt/V value. These systems offer a high
measurement rate, which tightly reflects the course of dialysis
and eliminates the need for V estimation.9 However, because
of the problems related with calibration, maintenance, and
costs, urea sensors have not been used widely.
Conductivity methods are based on the observation
that sodium and urea clearance are almost equal. It is
possible to measure sodium transfer from dialysate to blood
or vice versa, and by extension the urea clearance K of
the dialyzer.10 In addition, an anthropometric estimation,
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or a bioimpedance measurement of the urea distribution
volume of the patient V, is required for a final Kt/V
calculation. Although conductivity methods offer a good
measurement of the sodium clearance;11,12 (i) the estimation
of V introduces a major uncertainty;13 (ii) the measurement
requires changes of the conductivity level of the dialysis fluid
(which might influence the plasma composition of the
patient);14 (iii) the obtained K represents the membrane
performance, but does not give information regarding the
patient’s hemodynamic idiosyncrasies; and (iv) the measure-
ment frequency does not suffice to monitor the course of the
dialysis treatment.
High-performance liquid chromatography studies re-
ported that many substances present in the uremic serum
are active in the ultraviolet (UV) range of the light spectra.15
These studies led to the development of spectrophotometric
sensors. Monitoring UV-absorbing compounds in spent
dialysate not only offers enough data to tightly monitor a
dialysis treatment, but also eliminates the need for V,
by directly obtaining the ratio K/V from the decaying
absorbance curve. This technique was first reported by
Ga´l et al.;16 the investigators measured at 254 nm wavelength.
Recently, Uhlin et al.17 have shown good agreement between
the traditional blood eKt/V values (1.30±0.20) and the
eKt/V obtained with UV absorbance at 280 nm (1.19±0.23).
In this work, the UV-Kt/V was calculated by (i) applying
the natural logarithm to the measured absorbance decay,
and (ii) by fitting the resulting line using a linear fitting
procedure. This algorithm, however, has a drawback: if the
clearance is impaired during the treatment, for example,
because of secondary membrane formation or access
recirculation, less urea diffuses to the dialysate side, resulting
in a higher slope and a higher Kt/V, suggesting better dialysis,
when in fact, it is worse.
This work compares traditional blood eKt/V with
UV-eKt/V, which has been measured by a UV measuring
cell totally integrated in the dialysis machine. An enhanced
calculation algorithm that can overcome the Kt/V over-
estimation problem described above has been used. Two
clinical studies are presented here: S1, which compares
the ‘gold standard’ of serial blood urea measurements
to tightly monitor the blood urea concentration decay
with the UV-Kt/V method; and S2, which compares the
UV-based eKt/V with the most-commonly used blood-based
‘Daugirdas’ eKt/V under routine hemodialysis condition.
RESULTS
Figure 1 shows the blood urea concentration curve, together
with the UV curve, of 4-h hemodialysis therapy, super-
imposed. UVabsorption values have been normalized to blood
urea concentration values to render a visual comparison.
Figure 2 shows the linear relation between the
UV absorbance and urea concentration of spent dialysate.
The s.d. between the actual measurements and the modeled
line was ±2%, which was considered to be the accuracy of
the UV sensor.
Study S1
Mean blood spKt/V was 1.36±0.25, and the mean blood
eKt/V was 1.20±0.23; whereas the mean UV-spKt/V was
1.41±0.27, and the mean UV-eKt/V was 1.24±0.24. Mean
absolute error between blood spKt/V and UV-spKt/V
was 0.09±0.06, while the mean absolute error between
blood eKt/V and UV-eKt/V was 0.08±0.05. No significant
difference (Mann–Whitney U-test (confidence interval (CI):
95%)) was found between blood values and UV values, either
in terms of spKt/V (P¼ 0.33) or in terms of eKt/V (P¼ 0.39).
A Pearson product moment correlation analysis was 0.93
for spKt/V and eKt/V; concordance was 0.92 for spKt/V and
eKt/V. (Figure 3 shows a scatter plot of the blood-based
eKt/V against the UV-based eKt/V. Figure 4 shows the
difference between both variables in a Bland–Altman plot.)
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Figure 1 |Blood urea concentration vs ultraviolet
(UV) absorbance. Both curves are superimposed based on blood
urea concentration. UV absorbance has been normalized to the
blood concentration values to render a visual comparison.
Normalization resulted from multiplying the UV absorbance
values by a constant factor, that is, 115.02.
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Figure 2 | Linear relation between ultraviolet (UV) absorbance
and urea concentration. The s.d. between the actual measured
points and the modeled line is ±2%, which was considered
to be the accuracy of the UV sensor.
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Study S2
Mean blood spKt/V was 1.42±0.24, and mean blood eKt/V
was 1.25±0.21; whereas mean UV-spKt/V was 1.44±0.22,
and mean UV-eKt/V was 1.27±0.2. Mean absolute error
between blood spKt/V and UV-spKt/V was 0.12±0.09, while
the mean absolute error between blood eKt/V and UV-eKt/V
was 0.10±0.08. No significant differences (Mann–Whitney
U-test (CI: 95%)) were found between blood values and
UV values, either in terms of spKt/V (P¼ 0.47) or in terms of
eKt/V (P¼ 0.49). The Pearson product moment correlation
analysis was 0.80 for eKt/V; concordance was 0.80 for eKt/V.
(Figure 5 shows a scatter plot of the blood-based eKt/V
against the UV-based eKt/V. Figure 6 shows the difference
between both variables in a Bland–Altman plot. Figure 7 and
Table 1 summarize the results of both studies.)
DISCUSSION
The obtained results show the ability of the UV method to
accurately estimate the dialysis dosage in terms of Kt/V even
under routine hemodialysis conditions. The outstanding
correlation and concordance found during the study S1 are
attributed to the tight control of the blood urea concen-
tration, which was achieved by sampling the patient’s blood
every 20min over the treatment time (see Materials and
Methods). The lower correlation and concordance found
during study S2 are explained rather by the inherent
inaccuracies associated with the traditional blood-based
approach.
The course of UV absorbance closely follows urea
concentration, which shows that UV-absorbing compounds
follow a urea-like kinetic model, and validates the presented
UV approach as a reliable method to measure the Kt/V
parameter (Figure 1).
Uhlin et al.17 found that UV-based values were syste-
matically 10% lower than the blood-based values. The
investigators attribute the deviation to the higher molecular
weight of the UV-absorbing compounds, and by extension
to its lower clearance. However, in 1991, Garred et al.9 found
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Figure 3 | Study S1: blood eKt/V plotted against ultraviolet
(UV) eKt/V. r¼ 0.93; intraclass correlation coefficient (ICC)¼ 0.92;
n¼ 64; solid line: identity line; dashed line: least squares linear
correlation line.
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Figure 4 | Study S1: Bland–Altman blood eKt/V against
ultraviolet (UV) eKt/V. r¼ 0.93; intraclass correlation coefficient
(ICC)¼ 0.92; n¼ 64.
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Figure 5 | Study S2: Blood eKt/V plotted against ultraviolet
(UV) eKt/V. r¼ 0.801; intraclass correlation coefficient (ICC)¼ 0.8;
n¼ 217; solid line: identity line; dashed line: least squares linear
correlation line.
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Figure 6 | Study S2: Bland–Altman blood eKt/V against
ultraviolet (UV) eKt/V. r¼ 0.801; intraclass correlation coefficient
(ICC)¼ 0.8; n¼ 217.
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exactly the same systematic deviation when fitting urea
concentration data in spent dialysate. Both research groups
neglected the double-pool nature of the human body and
assumed single-pool kinetics, in which the UV absorbance
(A) or urea concentration (C) over the therapy time can be
described as follows:
At ¼ A0eK=Vt orCt ¼ C0eK=Vt ð1Þ
where K is the clearance of the dialysis procedure, V is the urea
distribution volume, and t is the treatment time in minutes.
In both cases, the same calculation algorithm was used:
first, linearization of the exponential decay by applying the
natural logarithm to the measured values –At or Ct–; and
second, a subsequent linear fit of the data pairs –ln(At)-time
or ln(Ct)-time–. Output of the fitting procedure was the ratio
K/V, which, when multiplied by the treatment time, resulted
in the Kt/V value.
Figure 8a shows the result of fitting a single exponential
function (equation (1)) to double-pool absorbance data in
spent dialysate. The lack of agreement between both curves
may be the reason for the reported deviations.
In our approach, the absorbance curve is split into fixed-
time intervals; each of these intervals is individually fit, and
yields a partial Kt/V value; finally, the overall Kt/V is obtained
by adding each partial Kt/V value (Figure 8b). In contrast to
the linearization approach (described by previous investiga-
tors), we improved the fit quality by using an iteration-based
algorithm, that is, Levenberg–Marquardt, which directly fits
the exponential curve (data not shown).
With these algorithm enhancements, we could consider-
ably reduce the systematic difference between blood and
UV, and minimize the effects of Kt/V overestimation in case
of sudden clearance impairment during the treatment. The
remaining error, UV-eKt/V is 3.3% higher than blood-eKt/V,
may indeed be introduced by using blood urea concentration
as a reference.
The UV-eKt/V showed a 7% nonsystematic error for full
eKt/V, contrasting with up to 18% attributed to conductivity-
based methods.18 This higher error is because of the need for
an anthropometric estimation of V, that is, Watson formulae.
In the UV method, the ratio K/V is directly obtained by fitting
the decaying absorbance curve, and then multiplying it by the
treatment time to get a final Kt/V value. This is carried out
without the need of either an estimation or an independent
measurement of the urea distribution volume V.19
The presented UV method is less-sensitive to measure-
ment errors than the blood-sampling-based procedure.
Overestimation risk of the Kt/V value in case of dialyzer
clotting can be controlled by proper calculation algorithm,
monitoring the pressure difference between dialyzer inlet and
outlet, and monitoring deviations of the expected absorbance
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Figure 7 |Blood-based eKt/V vs ultraviolet (UV)-based eKt/V.
Study S1: the mean blood eKt/V was 1.20±0.23, whereas the
mean UV-eKt/V was 1.24±0.24. Study S2: the mean blood eKt/V
was 1.25±0.21, whereas the mean UV-eKt/V was 1.27±0.2.
Table 1 | Results summary
Blood UV n Errora MW r ICC
Study S1
spKt/V 1.36±0.25 1.41±0.27 64 0.09±0.06 P=0.33 0.93 0.92
eKt/V 1.20±0.23 1.24±0.24 64 0.08±0.05 P=0.39 0.93 0.92
Study S2
spKt/V 1.42±0.24 1.44±0.22 217 0.12±0.09 P=0.47 0.79 0.79
eKt/V 1.25±0.21 1.27±0.2 217 0.10±0.08 P=0.49 0.80 0.80
Abbreviations: ICC, intraclass correlation coefficient; MW, Mann–Whitney U-test;
r: Pearson product moment correlation analysis; UV, ultraviolet.
aMean absolute error.
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Figure 8 | Effect of the calculation algorithm on fit goodness.
A single exponential fit to the whole absorbance curve shows
underestimation during the first hour, overestimation in the
middle, and again underestimation at the end of treatment (a);
whereas multiple single exponential fits to subsets of the
absorbance curve closely follow the real measured data (b).
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decay. The measuring principle, together with the high
sampling rate, tightly reflects the course of the dialysis from
the patient point of view, instead of merely assessing the
dialyzer clearance.
The results show a close concordance between the blood-
based and UV-based eKt/V-values. On-line monitoring of UV
absorption of spent dialysate is thus applicable in routine
hemodialysis to allow continuous measurement of removed
solutes from spent dialysate and direct surveillance of the
dialysis course without disturbing either the patient or the
treatment session.
MATERIALS AND METHODS
Dialysis centers
Study S1 was an anonymous monocentric study, conducted in
the Nieren- and Hochdruckzentrum Bad Wildungen. Study S2
was conducted in two centers, the PHV Dialysezentrum Melsungen
and the Nieren- and Hochdruckzentrum Bad Wildungen.
Patients
The study protocol was reviewed by the Freiburger Ethik-Komission
GmbH International in Freiburg, Germany, which declared the
study as non-interventional. A contract was signed with the medical
direction of each center, in which the nephrologist in charge
assumed the responsibility of informing the included patients and
getting their consents.
In total, 15 uremic patients (4 women, 11 men; mean age,
65.5 years; range, 45–85 years) with either an arteriovenous fistula or
an arteriovenous graft on chronic hemodialysis therapy three times a
week were included in study S1. Blood flow ranged from 230 to
370ml/min, and dialysate flow was 500ml/min. In all, 82 sessions
were recorded.
In total, 18 uremic patients (8 women, 10 men; mean age,
64.4 years; range, 22–86 years) with either an arteriovenous fistula or
an arteriovenous graft on chronic hemodialysis therapy three times a
week were included in study S2. Blood flow ranged from 200 to
400ml/min, and dialysate flow was 500ml/min. In all, 251 sessions
were recorded.
Three different types of dialyzers were used: high-flux poly-
sulfone, with an effective membrane area of 1.5m2; high-flux
polysulfone, with an effective membrane area of 1.8m2; and low-
flux polysulfone with an effective membrane area of 1.5m2 (Diacap
HI PS 15, HI PS 18 and LO PS 15, B Braun Avitum AG, Melsungen,
Germany). The dialysis machine Dialogþ (B Braun AG) with a built
in UV-Spectrophotometer (Option Adimea, B Braun AG) was used
in all recording sessions.
Blood sampling and laboratory analysis
Study S1 was aimed at avoiding the inaccuracies owing to post-
dialysis blood-sampling time. Blood samples were taken from the
arterial port of the extracorporeal tube system at 5 and 15min after
the therapy start; every 20min during the therapy; and 5min before
the end of the therapy. The intratherapy blood urea concentration
data (Ct) was fit to the equation (2), using an iteration-based
algorithm, that is, Levenberg–Marquardt. Output of the fitting
procedure was the ratio K/V, which, when multiplied by the therapy
time, resulted on a first Kt/V value.
Ct ¼ C0eK=Vt ð2Þ
The Daugirdas formulae20 were further used to express the obtained
Kt/V in terms of spKt/V, to account for urea generation and
ultrafiltration; and in terms of eKt/V, to account for the double-pool
nature of the human body. The blood-based spKt/V and eKt/V were
compared against their respective UV counterparts.
During the S2 study, blood samples were drawn before and after
the dialysis treatment. The error owing to access and cardio-
pulmonary recirculation was minimized by taking the post-dialysis
blood sample after the standard procedure described in the Kidney
Disease Outcomes Quality Initiative guidelines.21 The blood urea
concentration values, together with treatment time, ultrafiltration,
and patient dry weight, were used to calculate spKt/V and eKt/V
values by applying the Daugirdas formulae. These blood-based
values were taken as reference, and compared with their respective
UV-based values.
Urea concentrations were determined at the MVZ Laborzentrum
Kassel GmbH using the UV kinetic test on a Hitachi/Roche (Basel,
Switzerland) modular device. The variation coefficient of the urea
determination procedure was ±2%.
UV-absorbance monitoring
A double-beam, UV spectrophotometer, measuring at 280-nm
wavelength (Option Adimea, B Braun Avitum AG) coupled with the
out flowing water system of the dialysis machine (Dialogþ , B Braun
Avitum AG) was used to monitor continuously the spent dialysate.
The UV-absorbance A was calculated as follows:
At ¼ log10
I0
It
ð3Þ
where I0 is the transmission of light when measuring fresh dialysate
during preparation, and It is the transmission of light when
monitoring spent dialysate during therapy.
Accuracy of the UV sensor was assessed by measuring UV
absorbance on a battery of spent dialysate dilutions with different
urea concentrations. The linear relation between absorbance and
concentration was found. The s.d. between measured concentrations
and modeled line was considered the accuracy of the UV sensor.
During treatment, UV absorption was measured every 3min,
which allows approximately 80 measurements in a standard 4-h
dialysis. The investigators found that using higher sampling rates
does not further improve accuracy (data not shown). An algorithm
integrated in the software of the dialysis machine processed the UV
absorbance readings, calculated the accumulated Kt/V for every new
absorbance value, and showed the Kt/V and urea reduction ratio
trends in the machine’s display.
UV-Kt/V calculation algorithm
The calculation algorithm differed from the one used in previous
works.9,17 Instead of using the absorbance curve as a whole, it was
divided in intervals of 20min. A standard 4-h hemodialysis therapy
had 12 intervals with approximately 7 absorbance readings in each.
The investigators found that using 12 intervals optimizes accuracy of
the method (data not shown). An iterative procedure, that is, the
Levenberg–Marquardt algorithm, was used to fit each collection
of absorbance readings to equation (1). The fit output was the ratio
K/V, which, when multiplied by the interval time, resulted in the
Kt/V achieved during the considered interval. The whole therapy
Kt/V was calculated by adding up each of the obtained partial
Kt/Vs (Figure 8b).
The calculation algorithm also accounted for changes in the
treatment parameters having an effect on the K/V ratio: blood and
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dialysate flow. A change in these parameters triggered a new
interval, regardless of whether the defined 20min were over.
This approach assured that all the absorbance measurements
belonging to the same collection were recorded under constant
treatment conditions.
The Daugirdas formulae19 were used to further express the
obtained UV-Kt/V in terms of UV-spKt/V, to account for urea
generation and ultrafiltration, and in terms of UV-eKt/V to account
for the double-pool nature of the human body.
Statistical analyses
During study S1, dialyzer second membrane effects were controlled
by monitoring the pressure difference between blood-side dialyzer
inlet and outlet. Sessions showing a change on the pressure drop
along the dialyzer 430mmHg during the treatment were excluded
because of blood clotting. In all, 18 out of 82 sessions were excluded
from the statistical analysis: 1 because of UV-sensor failure; 4
because of blood-sampling or laboratory errors; 1 because of
dialyzer clotting; (patient 4 (6 sessions) was totally excluded because
of dialyzer clotting, which was reported by the nurses and detected
by the pressure monitoring, and patient 10 (6 sessions) was totally
excluded because the medical direction reported unstable Kt/V
during the last quarter of 2008).
During the study S2, 34 out of 251 recorded sessions were
excluded: 24 because of UV-sensor failure, 4 because of lack of either
pre-dialysis or post-dialysis blood sample, and 6 because of
implausible blood values (most likely because of typos when
transcribing the data).
The results are expressed as mean±s.d. Blood values were always
taken as reference; hence, a positive deviation means higher blood
values, and a negative deviation means higher UV values. Each
obtained variable was tested for normality (Anderson–Darling test,
CI: 95%). Significant differences between variables were tested using
the Mann–Whitney U-test (no significant difference, CI: 95%).
Pearson product moment correlation analysis and intraclass
correlation coefficient or concordance was calculated for each pair
of corresponding variables (CI: 95%). Minitab Statistical Software
(version 15.1; Minitab; State College, PA, USA) was used for all
statistical calculations.
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